PCMC
BNGO icon

Planning Capital Management Corporation’s Bionano Genomics BNGO Stock Holding History

Planning Capital Management Corporation’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$459 Hold
17
– – ﹤0.01% 674
2024
Q2 		$685 Buy
+17
New +$934 ﹤0.01% 611

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return

Planning Capital Management Corporation's BNGO Position: Q3 2024 in Review

Planning Capital Management Corporation held its Bionano Genomics (BNGO) position steady in Q3 2024 at 17 shares worth $459. The position accounts for ﹤0.01% of the portfolio, ranked #674.

Planning Capital Management Corporation first reported a position in BNGO in Q2 2024 and has held it in 2 quarters since. The position peaked at $685 in Q2 2024. 47 funds tracked by Wall St. Rank hold BNGO as of Q3 2024.

  • Planning Capital Management Corporation held 17 shares of Bionano Genomics worth $459 as of Q3 2024.
  • Planning Capital Management Corporation left its Bionano Genomics share count unchanged in Q3 2024.
  • Bionano Genomics made up ﹤0.01% of Planning Capital Management Corporation's portfolio in Q3 2024, its #674 holding.
  • Planning Capital Management Corporation first reported a position in Bionano Genomics in Q2 2024 and has held it in 2 quarters since.
  • Planning Capital Management Corporation's Bionano Genomics position peaked at $685 in Q2 2024.
  • 47 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2024.

Based on Planning Capital Management Corporation's 13F filing for Q3 2024, filed 6 Nov 2024.